FDA Pre-Cert tested with Pear insomnia DTx.

Issue 011. FDA first Pre-Cert clearance: Likely Pear insomnia DTx. More Livongo.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a this-is-becoming-a-pattern 74 percent open rate. Here's what's happening this week:

Your editor's alarm goes off 2:30am each morning to take the young pup out. Last night a pack of coyotes was howling nearby. Happy to report: We're both here to tell the tale.
Wisconsin's state legislature is considering a bill that would create a statewide "diabetes action plan". Welldoc's Chief Strategy Officer Anand Iyer was in-committee as an expert witness. Full video (Iyer's testimony starts around 2hr 10min).
* Meanwhile, Scotland is setting up a new government body next year that oversees all things digital health, including digital therapeutics.
* Not much to this, but just noticed that Fitbit added

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

FDA Pre-Cert tested with Pear insomnia DTx.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.